Hysteroscopy
Conditions
Interventions
Intervention group:Tegileridine was administered intravenously with an initial dose of 15µg/kg and a dose gradient of 1.5µg/kg. The dose was adjusted according to the Dixon modified sequential method.
Sponsors
The People’s Hospital of Suzhou Gaoxin District
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients scheduled for hysteroscopy; 2. Age 18 to 65 years; 3.Body mass index (BMI) 18 to 28 kg/m^2; 4.American Society of Anesthesiologists (ASA) classification of grade I or II.
Exclusion criteria
Exclusion criteria: 1.One month before the surgery, there was chronic pain or the use of any painkillers; 2.Allergic to opioids; 3.Had a history of mental illness or cognitive dysfunction; 4.Had other somatic pain conditions that might affect the postoperative pain assessment; 5.Unable to complete the pain assessment; 6.Had a history of drug and/or alcohol abuse within 1 year before randomization; 7.Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ED50 and ED95 of Tigeline;Respiratory rate;End-tidal carbon dioxide;Mean arterial pressure;Heart rate;Pulse oximetry saturation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score; | — |
Countries
China
Contacts
Public ContactSun Yinyin
The People’s Hospital of Suzhou Gaoxin District
Outcome results
None listed